Viral infection enhancing peptide
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Feb 18, 2014
Grant Date -
May 17, 2012
app pub date -
Nov 16, 2011
filing date -
Nov 16, 2010
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The invention relates to a peptide derived from HIV-1 gp120 which forms insoluble aggregates when introduced into an aqueous solution and its use for enhancing viral infection of cells. In addition, the invention comprises methods for enhancing viral infection of cells, for concentrating a virus and for separating a virus from a fluid.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully